Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Medicine
|
July 19, 2016
Cerebrospinal fluid analysis for HIV replication and biomarkers of immune activation and neurodegeneration in long-term atazanavir/ritonavir monotherapy treated patients
Francesca Ferretti, Alba Bigoloni, Laura Passeri, et al.
Science Translational Medicine
|
August 21, 2024
Microglia-specific <i>IL-10</i> gene delivery inhibits neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease
Simone Bido, Melania Nannoni, Sharon Muggeo, et al.
Journal of Autoimmunity
|
May 24, 2023
Tolerogenic IL-10-engineered dendritic cell-based therapy to restore antigen-specific tolerance in T cell mediated diseases
Laura Passeri, Grazia Andolfi, Virginia Bassi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
November 21, 2025
Efficacy and Safety of Lenvatinib Versus Sorafenib in Recurrent HCC After Liver Transplant: A Multi-Center Real-World Study
Federica Lo Prinzi, Federico Rossari, Antonio De Rosa, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 2, 2026
Early and late survival dynamics of immunotherapy combinations in advanced HCC: Anchored indirect comparison of atezolizumab plus bevacizumab versus durvalumab + tremelimumab
Andrea Casadei-Gardini, Terry Cheuk-Fung Yip, Alessandro Vitale, et al.
Targeted Oncology
|
February 27, 2026
Prognostic Impact of Metastatic Sites in Patients with Biliary Tract Cancer Treated with Cisplatin, Gemcitabine, and Durvalumab
Silvia Camera, Lorenzo Fornaro, Margherita Rimini, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 12, 2025
Durvalumab in Advanced Biliary Tract Cancer: Real-World Data From a Large Cohort of Patients Across Multiple International Centers
Margherita Rimini, Lorenzo Fornaro, Masafumi Ikeda, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 17, 2025
A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC-D Index
Mara Persano, Margherita Rimini, Francesca Salani, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Medicine
|
July 19, 2016
Cerebrospinal fluid analysis for HIV replication and biomarkers of immune activation and neurodegeneration in long-term atazanavir/ritonavir monotherapy treated patients
Francesca Ferretti, Alba Bigoloni, Laura Passeri, et al.
Science Translational Medicine
|
August 21, 2024
Microglia-specific <i>IL-10</i> gene delivery inhibits neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease
Simone Bido, Melania Nannoni, Sharon Muggeo, et al.
Journal of Autoimmunity
|
May 24, 2023
Tolerogenic IL-10-engineered dendritic cell-based therapy to restore antigen-specific tolerance in T cell mediated diseases
Laura Passeri, Grazia Andolfi, Virginia Bassi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
November 21, 2025
Efficacy and Safety of Lenvatinib Versus Sorafenib in Recurrent HCC After Liver Transplant: A Multi-Center Real-World Study
Federica Lo Prinzi, Federico Rossari, Antonio De Rosa, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 2, 2026
Early and late survival dynamics of immunotherapy combinations in advanced HCC: Anchored indirect comparison of atezolizumab plus bevacizumab versus durvalumab + tremelimumab
Andrea Casadei-Gardini, Terry Cheuk-Fung Yip, Alessandro Vitale, et al.
Targeted Oncology
|
February 27, 2026
Prognostic Impact of Metastatic Sites in Patients with Biliary Tract Cancer Treated with Cisplatin, Gemcitabine, and Durvalumab
Silvia Camera, Lorenzo Fornaro, Margherita Rimini, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 12, 2025
Durvalumab in Advanced Biliary Tract Cancer: Real-World Data From a Large Cohort of Patients Across Multiple International Centers
Margherita Rimini, Lorenzo Fornaro, Masafumi Ikeda, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 17, 2025
A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC-D Index
Mara Persano, Margherita Rimini, Francesca Salani, et al.
Page
of 2